Search - tctmd.com

Displaying 981 - 1000 of 3006

Sort: Relevancy | Date

Presentation TCT 2019

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Presenter: Greg Kaluza

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Presenter: Shao-Liang Chen

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

TCT 72: Validation of Complex Bifurcation Lesion Definition and Comparing Stenting Strategy in a Large Cohort of Patients with Left Main Bifurcation

Presenter: Changdong Guan

September 25, 2019

Presentation TCT 2019

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

Presenter: Nicolas Shammas

September 25, 2019

Presentation TCT Abstracts Posters 2019

Excimer Laser Coronary Angioplasty for Stent Under-Expansion: Single Center Experience and Outcomes

Presenter: John Nan

September 25, 2019

Presentation TCT 2019

TCT 67: Predictors and Outcomes After Stent Failure Is Treated with Either CABG or PCI: An Individual Patient-Data Pooled Analysis From 32,880 Patients

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

Presenter: Lei Song

September 25, 2019

Presentation TCT 2019

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

Presenter: Hector Tamez

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation TCT 2019

Case 4 (From S. Korea): Upfront 3 Stent for Left Main Trifurcation Disease

Presenter: Seung-Jung Park

September 25, 2019

Presentation TCT 2019

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

Presenter: Junjie Zhang

September 25, 2019

Presentation TCT 2019

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

Presenter: Takahiro Jimba

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

Presenter: Bernhard Witzenbichler

September 25, 2019

Presentation TCT 2019

TCT 19: Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During TAVR: an International Multicenter Registry

Presenter: Antonio Mangieri

September 25, 2019

Advertisement

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Potential Hazards of Re-Stenting

TCT 72: Validation of Complex Bifurcation Lesion Definition and Comparing Stenting Strategy in a Large Cohort of Patients with Left Main Bifurcation

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?

Excimer Laser Coronary Angioplasty for Stent Under-Expansion: Single Center Experience and Outcomes

TCT 67: Predictors and Outcomes After Stent Failure Is Treated with Either CABG or PCI: An Individual Patient-Data Pooled Analysis From 32,880 Patients

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

TCT 65: Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention Among Medicare Beneficiaries

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Case 4 (From S. Korea): Upfront 3 Stent for Left Main Trifurcation Disease

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

TCT 19: Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction During TAVR: an International Multicenter Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content